This article is a correction to:
Efficient In Vitro Generation of IL-22-Secreting ILC3 From CD34+ Hematopoietic Progenitors in a Human Mesenchymal Stem Cell Niche
Sabrina B. Bennstein1Sandra Weinhold1Özer Degistirici2Robert A. J. Oostendorp3Katharina Raba1Gesine Kögler1Roland Meisel2Lutz Walter4
Markus Uhrberg1*- 1Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany
- 2Division of Pediatric Stem Cell Therapy, Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Center for Children and Adolescence Health, Heinrich-Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany
- 3Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Internal Medicine III – Hematology and Oncology, Laboratory of Stem Cell Physiology, Munich, Germany
- 4Primate Genetics Laboratory, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany
A Corrigendum on
Efficient in vitro generation of IL-22-secreting ILC3 from CD34+ hematopoietic progenitors in a human mesenchymal stem cell niche
by Bennstein SB, Weinhold S, Degistirici Ö, Oostendorp RAJ, Raba K, Kögler G, Meisel R, Walter L and Uhrberg M (2021) 12:797432. doi: 10.3389/fimmu.2021.797432
In the published article, there was an error in the Funding statement. A funding source of the author Roland Meisel was mistakenly not included in the publication. The correct Funding statement appears below.
Funding
This work was supported by funds from the Düsseldorf School of Oncology (funded by the Comprehensive Cancer Center Düsseldorf/Deutsche Krebshilfe and the Medical Faculty HHU Düsseldorf) and the Deutsche Forschungsgemeinschaft (DFG) FOR2033, TP B3 (RO), SPP1937-UH91/8-1 and UH91/10-1 (both MU). This work was partially supported by funds from the Bundesministerium für Bildung und Forschung (BMBF) MyPred, 01GM1911E to RM.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: CD34 cells+, mesenchymal stem cells, umbilical cord stem cells (UCSC), innate lymphoid cells (ILCs), ILC3, hematopoietic stem and progenitor cells, GMP—Good Manufacturing Practice
Citation: Bennstein SB, Weinhold S, Degistirici Ö, Oostendorp RAJ, Raba K, Kögler G, Meisel R, Walter L and Uhrberg M (2023) Corrigendum: Efficient in vitro generation of IL-22-secreting ILC3 from CD34+ hematopoietic progenitors in a human mesenchymal stem cell niche. Front. Immunol. 14:1292209. doi: 10.3389/fimmu.2023.1292209
Received: 11 September 2023; Accepted: 12 September 2023;
Published: 22 September 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Bennstein, Weinhold, Degistirici, Oostendorp, Raba, Kögler, Meisel, Walter and Uhrberg. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Markus Uhrberg, TWFya3VzLlVocmJlcmdAbWVkLnVuaS1kdWVzc2VsZG9yZi5kZQ==